Susceptibility of recently collected spanish pneumococci nonsusceptible to oral penicillin from serotypes not included in the 7-valent conjugate vaccine

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 6, 2010, Pages 2696-2698

  Fenoll, Asunción ^a   Aguilar, Lorenzo ^b   Giménez, María José ^b   Vicioso, María Dolores ^a   Robledo, Olga ^a   Granizo, Juan José ^c   Coronel, Pilar ^d  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b SCHOOL OF MEDICINE   (Spain)

^c Scientific Department ^*  (Spain)

^d Scientific Department   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFDINIR; CEFDITOREN; CEFOTAXIME; CEFPODOXIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; ERYTHROMYCIN; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; MINIMUM INHIBITORY CONCENTRATION; PENICILLIN RESISTANCE; PRIORITY JOURNAL; SPAIN; STREPTOCOCCUS;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; PENICILLINS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROTYPING; SPAIN; SPECIES SPECIFICITY; STREPTOCOCCUS PNEUMONIAE;

EID: 77952654544     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01594-09     Document Type: Article

References (12)

1. Ardanuy, C., D. Rolo, A. Fenoll, D. Tarrago, L. Calatayud, and J. Liñares. 2009. Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain. J. Antimicrob. Chemother. 64:507-510.
2. Ardanuy, C., F. Tubau, R. Pallares, L. Calatayud, M. A. Domínguez, D. Rolo, I. Grau, R. Martín, and J. Liñares. 2009. Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007. Clin. Infect. Dis. 48:57-64.
3. Centers for Disease Control and Prevention. 2008. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction - eight states, 1998-2005. MMWR Morb. Mortal. Wkly. Rep. 57:144-148.
4. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing: 19th informational supplement M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Fenoll, A., L. Aguilar, J. J. Granizo, M. J. Giménez, L. Aragoneses-Fenoll, C. Mendez, and D. Tarragó. 2008. Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial nonsusceptibility in invasive Streptococcus pneumoniae? J. Antimicrob. Chemother. 62:1430-1433.
6. Fenoll, A., J. J. Granizo, L. Aguilar, M. J. Giménez, L. Aragoneses-Fenoll, G. Hanquet, J. Casal, and D. Tarragó. 2009. Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J. Clin. Microbiol. 47:1012-1020.
7. Fenoll, A., I. Jado, D. Vicioso, and J. Casal. 1997. Dot blot assay for the serotyping of pneumococci. J. Clin. Microbiol. 35:764-766.
8. Garcia-Rey, C., L. Aguilar, F. Baquero, J. Casal, and R. Dal-Re. 2002. Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae. J. Clin. Microbiol. 40:159-164.
9. Mahjoub-Messai, F., C. Doit, J. L. Koeck, T. Billard, B. Evrard, P. Bidet, C. Hubans, J. Raymond, C. Levy, R. Cohen, and E. Bingen. 2009. Population snapshot of Streptococcus pneumoniae serotype 19A isolates before and after the introduction of 7-valent pneumococcal vaccination in French children. J. Clin. Microbiol. 47:837-840.
10. Moore, M. R., R. E. Gertz, Jr., R. L. Woodbury, G. A. Barkocy-Gallagher, W. Schaffner, C. Lexau, K. Gershman, A. Reingold, M. Farley, L. H. Harrison, J. L. Hadler, N. M. Bennett, A. R. Thomas, L. McGee, T. Pilishvili, A. B. Brueggemann, C. G. Whitney, J. H. Jorgensen, and B. Beall. 2008. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J. Infect. Dis. 197:1016-1027.
11. Pelton, S. I., H. Huot, J. A. Finkelstein, C. J. Bishop, K. K. Hsu, J. Kellenberg, S. S. Huang, R. Goldstein, and W. P. Hanage. 2007. Emergence of 19A as virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr. Infect. Dis. J. 26:468-472.
12. Singleton, R. J., T. W. Hennessy, L. R. Bulkow, L. L. Hammitt, T. Zulz, D. A. Hurlburt, J. C. Butler, K. Rudolph, and A. Parkinson. 2007. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 297:1784-1792.